Non-invasive tests-based risk stratification: Baveno VII and beyond

Non-invasive tests-based risk stratification: Baveno VII and beyond

Bibliographic Details
Main Authors:	Georg Semmler, Mathias Jachs, Mattias Mandorfer
Format:	Article
Language:	English
Published:	Korean Association for the Study of the Liver 2023-01-01
Series:	Clinical and Molecular Hepatology
Subjects:	hypertension portal elasticity imaging techniques liver cirrhosis
Online Access:	http://e-cmh.org/upload/pdf/cmh-2022-0361.pdf

Similar Items

The rise of non-invasive tools in the diagnosis of portal hypertension: Validation of the Baveno VII consensus
by: Jeong-Ju Yoo, et al.
Published: (2023-01-01)

Baveno-VII criteria to predict decompensation and initiate non-selective beta-blocker in compensated advanced chronic liver disease patients
by: Yu Jun Wong, et al.
Published: (2023-01-01)

Correspondence on Editorial regarding “Baveno-VII criteria to predict decompensation and initiate non-selective beta-blocker in compensated advanced chronic liver disease patients”
by: Yu Jun Wong, et al.
Published: (2023-01-01)

Baveno VII criteria to predict decompensation in compensated advanced chronic liver disease: Still some shades of grey
by: Susana G. Rodrigues
Published: (2023-01-01)

Platelet adhesion assessed by PFA-100 is not linked to progression of ACLD
by: Lorenz Balcar, et al.
Published: (2024-01-01)

Principles and clinical application of ultrasound elastography for diffuse liver disease
by: Woo Kyoung Jeong, et al.
Published: (2014-07-01)

Baveno VI Recommendation on Avoidance of Screening Endoscopy in Cirrhotic Patients: Not Quite There Yet!
by: Susana Rodrigues
Published: (2017-02-01)

Portal hypertension V : proceedings of the Fifth Baveno International Consensus Workshop /
by: Baveno International Consensus Workshop (5th), et al.
Published: (2011)

Variability of transient elastography-based spleen stiffness performed at 100 Hz
by: Angelo Armandi, et al.
Published: (2023-12-01)

Long-Term Outcome of HBV-Infected Patients with Clinically Significant Portal Hypertension Achieving Viral Suppression
by: Mathias Jachs, et al.
Published: (2022-02-01)

Liver stiffness assessment as an alternative to hepatic venous pressure gradient for predicting rebleed after acute variceal bleed: A proof‐of‐concept study
by: Samagra Agarwal, et al.
Published: (2021-01-01)

The cut-off value of transient elastography to the value of hepatic venous pressure gradient in alcoholic cirrhosis
by: Se Ri Ryu, et al.
Published: (2021-01-01)

Ascites
by: Soung Won Jeong
Published: (2018-08-01)

Colonic mucosal changes in Egyptian patients with liver cirrhosis and portal hypertension
by: Zakaria A Salama, et al.
Published: (2013-01-01)

CASE REPORT: LIVER CIRRHOSIS
by: Pande Made Aditya Saskara, et al.
Published: (2013-04-01)

Aspartate aminotransferase-to-platelet ratio index (APRI) for the non-invasive prediction of esophageal varices
by: Ângelo Zambam de Mattos, et al.
Published: (2013-09-01)

Investigation of computed tomography findings of portal hypertension at non-alcoholic fatty liver disease
by: Fatma Kulali, et al.
Published: (2016-09-01)

Increases in Autoantibody Level Associated with Degenerative Changes in the Intestinal Mucosa in Liver Cirrhosis
by: Karpova RV, et al.
Published: (2020-08-01)

Less known but important complications and associated anomalies of Abernethy malformation
by: Ayşe Rüksan Ütebey, et al.
Published: (2023-03-01)

Hepatic venous pressure gradient measurement in pre-primary and primary prophylaxis of variceal hemorrhage
by: Julio D. Vorobioff, M.D., et al.
Published: (2013-01-01)

Surgical treatment of portal hypertension complications in patients with liver cirrhosis
by: V. M. Durleshter, et al.
Published: (2022-09-01)

Role of the spleen in patients with liver cancer and cirrhosis
by: CHANG Jessica, CHEN Xuxiao, CHEN Yongjun
Published: (2023-07-01)

A patient with dyskeratosis congenita and portal hypertension
by: Min Wei, et al.
Published: (2023-06-01)

PORTAL HYPERTENSION: TREATMENT FEATURES (REVIEW OF LITERATURE)
by: N. G. Sapronova
Published: (2014-06-01)

Tumor Recurrence in Hepatocellular Carcinoma Patients after Radiofrequency Ablation: Portal Hypertension as an Indicator of Recurrence of Hepatocellular Carcinoma
by: Seong Won Jang, et al.
Published: (2018-11-01)

THE IMPACT OF THE SURGICAL DECISION IN THE CLINICAL EVOLUTION OF THE CIRRHOTIC PATIENT OPERATED FOR PORTAL HYPERTENSION (A REVIEW)
by: Vladimir Cazacov, et al.
Published: (2019-12-01)

Aspects of pathogenetic pharmacotherapy for portal hypertension in liver cirrhosis
by: D V Garbuzenko
Published: (2016-02-01)

The cutoff of transient elastography for the evaluation of portal hypertension should be different according to the etiology?
by: Beom Kyung Kim
Published: (2021-01-01)

The Right Liver Lobe Size/Albumin Concentration Ratio in Identifying Esophageal Varices among Patients with Liver Cirrhosis
by: Muhammad Akram, et al.
Published: (2019-01-01)

Effect of Treatment with Direct Acting Antiviral on Glycemic Control in Patients with Diabetes Mellitus and Chronic Hepatitis C
by: Jonathan G. Stine, et al.
Published: (2017-03-01)

Ratio of the blood flow in liver and splenic arteries in patients with various forms of portal hypertension
by: A. S. Tugushev, et al.
Published: (2015-12-01)

A case of variceal bleeding from the jejunum in liver cirrhosis
by: Chan Woong Park, et al.
Published: (2013-03-01)

An impaired pituitary–adrenal signalling axis in stable cirrhosis is linked to worse prognosis
by: Lukas Hartl, et al.
Published: (2023-08-01)

Beyond the scope and the glue: update on evaluation and management of gastric varices
by: Cyriac Abby Philips, et al.
Published: (2020-10-01)

Dysregulated biomarkers of innate and adaptive immunity predict infections and disease progression in cirrhosis
by: Benedikt Simbrunner, et al.
Published: (2023-05-01)

Diagnostic validity of serum YKL-40 as a non-invasive diagnostic marker of oesophageal varices in cirrhotic hepatitis C virus patients
by: Abdelfattah Hanno, et al.
Published: (2022-08-01)

A rapid, non-invasive, clinical surveillance for CachExia, sarcopenia, portal hypertension, and hepatocellular carcinoma in end-stage liver disease: the ACCESS-ESLD study protocol
by: Patrik Nasr, et al.
Published: (2023-12-01)

Non-Invasive Predictors of Esophageal Varices in Alcoholic Chronic Liver Disease
by: Rishab Shrestha, et al.
Published: (2019-12-01)

Characteristics of gastric microbiota in cirrhotic patients with portal hypertension
by: MU Zhiyong, et al.
Published: (2022-08-01)

Oxidative Mechanisms and Cardiovascular Abnormalities of Cirrhosis and Portal Hypertension
by: Hongqun Liu, et al.
Published: (2023-11-01)